TH154821A - Fudge ring quinolil pyrolopyrimidil compound Or the salt of this substance - Google Patents
Fudge ring quinolil pyrolopyrimidil compound Or the salt of this substanceInfo
- Publication number
- TH154821A TH154821A TH1401004803A TH1401004803A TH154821A TH 154821 A TH154821 A TH 154821A TH 1401004803 A TH1401004803 A TH 1401004803A TH 1401004803 A TH1401004803 A TH 1401004803A TH 154821 A TH154821 A TH 154821A
- Authority
- TH
- Thailand
- Prior art keywords
- compound
- substance
- salt
- pyrolopyrimidil
- quinolil
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract 6
- 239000000126 substance Substances 0.000 title claims abstract 5
- 150000003839 salts Chemical class 0.000 title claims abstract 3
- 239000011780 sodium chloride Substances 0.000 title claims abstract 3
- 230000002401 inhibitory effect Effects 0.000 claims abstract 6
- 102000017256 epidermal growth factor-activated receptor activity proteins Human genes 0.000 claims abstract 4
- 108040009258 epidermal growth factor-activated receptor activity proteins Proteins 0.000 claims abstract 4
- 201000011510 cancer Diseases 0.000 claims abstract 2
- 230000010261 cell growth Effects 0.000 claims abstract 2
- 239000003814 drug Substances 0.000 claims abstract 2
- 239000000825 pharmaceutical preparation Substances 0.000 claims abstract 2
- 230000002265 prevention Effects 0.000 claims abstract 2
- 229940079593 drugs Drugs 0.000 claims 1
Abstract
DC60 (26/06/60) การประดิษฐ์นี้จัดให้มีสารประกอบใหม่ที่มีฤทธิ์ในการยับยั้งต่อ EGFR เเละมีผลในการยับยั้ง การเติบโตของเซล การประดิษฐ์นี้ยังจัดให้มีสารเตรียมทางเภสัชกรรมที่มีประโยชน์สำหรับการ ป้องกัน เเละ/หรือ การรักษามะเร็งโดยมีพื้นฐานอยู่บนผลการยับยั้ง EGFR ของสารประกอบนี้ โดย สารประกอบนี้เเสดงได้ด้วยสูตร (I) ต่อไปนี้ สูตรเคมี (I) หรือเกลือของสารนี้ สิทธิบัตรยา DC60 (26/06/60) This invention provides a new compound with an inhibitory effect on EGFR and has an inhibitory effect. Cell growth The invention also provides a useful pharmaceutical preparation for the prevention and / or treatment of cancer based on the EGFR-inhibiting effect of this compound. This chemical formula (I) or the salt of this substance, patent medicine.
Claims (1)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TH154821A true TH154821A (en) | 2016-08-01 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TH154821A (en) | Fudge ring quinolil pyrolopyrimidil compound Or the salt of this substance | |
| TH153174A (en) | Immidazopyridinone Compound | |
| TH170537A (en) | Chemical compound | |
| TH157676A (en) | Pyrazole compounds as SGLT1 inhibitors | |
| TH1901002344A (en) | Novel naphthyridone derivatives and their use in the treatment of cardiac arrhythmias. | |
| TH171202A (en) | Compounds and methods for treating bacterial infections | |
| TH1701001398A (en) | 1-alkyl-6-oxo-1,6-dihydropyridin-3-il compounds And using it as a SGRM controller | |
| TH159902A (en) | ||
| TH1601007046A (en) | Combined hetero-aerobic spyrocyclic compound for the treatment of Bacterial infection | |
| TH180844A (en) | Naphthyridine Dion derivatives | |
| TH171283A (en) | Tetrahydropyrolothiazine | |
| TH156811A (en) | Cancer-fighting pyridopyrazine by inhibiting FGFR kinase. | |
| TH1701003495A (en) | Triazolopyrimidine and its use | |
| TH165767B (en) | Substituteed compound Dihydroisokinolinone | |
| TH171902A (en) | Heterocyclic compounds | |
| TH167426A (en) | Hetero-aeryl or bicyclic-bonded aryl compounds and their use That substance as an IRAK4 inhibitor | |
| TH165767A (en) | Substituteed compound Dihydroisokinolinone | |
| TH159388A (en) | Macroxylic compounds and their production methods | |
| TH153609A (en) | New types of thiopyrimidine derivatives, the preparation process of these derivatives, and the pharmaceutical constituents that comprise them. | |
| TH168624A (en) | Glucopyranosil-substrate derivatives Indole-urea And the use of those substances As an SGLT inhibitor | |
| TH166748A (en) | Macro cyclic pyrimidine derivatives | |
| TH168863A (en) | Pirasol-amide compounds And its medical use | |
| TH1701004612A (en) | (2R, 4R) -5- (5'-Chloro-2'-Fluorobifenyl-4-Il) -2-hydroxy-4 - ((5-methyloxazole -2-carbonyl) amino) pentanoic acid | |
| TH169293A (en) | BACEI inhibitors | |
| TH1601006691A (en) |